Chu Wan-li, Liu Xue-feng, Liu Jun-ying, Zhang Qiang, Lin Zhao-fen
Burns Institute, First Affiliated Hospital of General Hospital of PLA, Beijing 100048, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 May;21(5):263-5.
To investigate the effect of recombinant rat ghrelin on gastric mucosa in rats with hemorrhagic shock.
Eighteen healthy male Sprague-Dawley (SD) rats were randomly assigned into three groups: control group, hemorrhagic shock group, and ghrelin treatment group, with 6 rats for each group. The hemorrhagic shock model was reproduced in hemorrhagic shock group and ghrelin treatment group, and recombinant rat ghrelin (20 microg/kg) was intravenously administered to rats in ghrelin treatment group when resuscitation begun. Two hours after resuscitation, the gastric mucosal blood flow (GMBF) was determined with laser Doppler flowmetry (LDF). The light microscope and transmission electron microscope (TEM) were used to assess gastric mucosal injury.
The GMBF of the rats in hemorrhagic shock group was significantly lower than that in control group [(260.4+/-49.6) bpu vs. (418.6+/-57.3) bpu, P<0.01], and the gastric mucosa was injured, presenting cell necrosis, cytolysis and focal ulceration. The GMBF of the rats in ghrelin treatment group was remarkably richer than that in hemorrhagic shock group [(352.9+/-72.9) bpu vs. (260.4+/-49.6) bpu, P<0.05], but had no significant difference compared with that in control group (P>0.05), and the gastric mucosa injuries were greatly improved in the rats of ghrelin treatment group.
Recombinant rat ghrelin, through enhancing the GMBF, can ameliorate the gastric mucosal ischemic/reperfusion injury in rats with hemorrhagic shock.
探讨重组大鼠胃饥饿素对失血性休克大鼠胃黏膜的影响。
将18只健康雄性Sprague-Dawley(SD)大鼠随机分为三组:对照组、失血性休克组和胃饥饿素治疗组,每组6只。失血性休克组和胃饥饿素治疗组复制失血性休克模型,胃饥饿素治疗组大鼠在复苏开始时静脉注射重组大鼠胃饥饿素(20微克/千克)。复苏2小时后,用激光多普勒血流仪(LDF)测定胃黏膜血流量(GMBF)。用光镜和透射电子显微镜(TEM)评估胃黏膜损伤。
失血性休克组大鼠的GMBF显著低于对照组[(260.4±49.6)bpu对(418.6±57.3)bpu,P<0.01],胃黏膜受损,表现为细胞坏死、细胞溶解和局灶性溃疡。胃饥饿素治疗组大鼠的GMBF明显高于失血性休克组[(352.9±72.9)bpu对(260.4±49.6)bpu,P<0.05],但与对照组相比无显著差异(P>0.05);胃饥饿素治疗组大鼠的胃黏膜损伤得到显著改善。
重组大鼠胃饥饿素可通过增加GMBF改善失血性休克大鼠胃黏膜缺血/再灌注损伤。